12:00 AM
 | 
Oct 22, 2012
 |  BC Week In Review  |  Company News  |  Other News

ElexoPharm, SomantiX B.V., PharmBioTec GmbH, Saarland University, VU University Medical Center cancer news

EuroTransBio awarded a three-year grant worth €1.5 million ($1.9 million) to a consortium to develop low molecular weight inhibitors of angiogenesis in colorectal...

Read the full 93 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >